Pharmacokinetics of maraviroc administered at 150 mg once daily in association with lopinavir/ritonavir in HIV-positive treatment-naive patients

J Antimicrob Chemother. 2013 Jul;68(7):1686-8. doi: 10.1093/jac/dkt074. Epub 2013 Mar 14.
No abstract available

Keywords: NRTI-sparing; PK; antivirals.

Publication types

  • Letter

MeSH terms

  • Adult
  • Anti-HIV Agents / administration & dosage*
  • Anti-HIV Agents / pharmacokinetics*
  • Cyclohexanes / administration & dosage*
  • Cyclohexanes / pharmacokinetics*
  • Drug Therapy, Combination / methods
  • HIV Infections / drug therapy*
  • Humans
  • Lopinavir / administration & dosage
  • Male
  • Maraviroc
  • Plasma / chemistry
  • Ritonavir / administration & dosage
  • Time Factors
  • Triazoles / administration & dosage*
  • Triazoles / pharmacokinetics*

Substances

  • Anti-HIV Agents
  • Cyclohexanes
  • Triazoles
  • Lopinavir
  • Maraviroc
  • Ritonavir